Effect of combination fluoxetine and exercise on prefrontal BDNF, anxiety-like behavior and fear extinction in a female rat model of post-traumatic stress disorder (PTSD): a comparison with male animals

Behav Brain Funct. 2023 Jan 16;19(1):1. doi: 10.1186/s12993-023-00204-z.

Abstract

Despite significant differences between men and women in the symptoms of PTSD and the response to therapeutic interventions, most PTSD studies have been done on male subjects. Continuing our previous study in male rats, this study aimed at better understanding the effect of a combination therapy of exercise with fluoxetine on female PTSD rats. The results were then compared with our past findings in male animals. Female adult Wistar rats subjected to PTSD were treated with moderate treadmill exercise or fluoxetine, or a combination of both. PTSD was induced by the single prolonged stress (SPS) model. Elevated plus-maze (EPM), serum and prefrontal BDNF, and fear extinctions were evaluated. The results showed that exercise plus fluoxetine decreased anxiety-like behavior, improved fear extinction, and increased BDNF changes in female rats. The effects of exercise alone were comparable with those of combination therapy except that combination therapy was more effective on OAT (open arm entry). The majority of results in female rats, except for those of prefrontal BDNF, 4th extinction, and OAT, were similar to those of male rats as shown in our previous study. According to our findings, exercise as a safe and cost-effective intervention can be considered as a complementary efficient option for PTSD treatment in both sexes. To achieve better treatment outcomes in PTSD patient, considering sex differences is recommended.

Keywords: Exercise; Fluoxetine; PTSD; Single prolonged stress; sex.

MeSH terms

  • Animals
  • Anxiety / drug therapy
  • Brain-Derived Neurotrophic Factor / metabolism
  • Disease Models, Animal
  • Extinction, Psychological / physiology
  • Fear / physiology
  • Female
  • Fluoxetine* / pharmacology
  • Fluoxetine* / therapeutic use
  • Male
  • Physical Conditioning, Animal*
  • Rats
  • Rats, Wistar
  • Stress Disorders, Post-Traumatic* / drug therapy

Substances

  • Brain-Derived Neurotrophic Factor
  • Fluoxetine